Skip to content

The Effect of Whey and Casein on IGFs in Prepubertal Boys

The Effect of Whey and Casein With and Without Milk Minerals on IGFs in Prepubertal Boys

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00378820
Enrollment
60
Registered
2006-09-21
Start date
2004-07-31
Completion date
2005-04-30
Last updated
2009-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Obesity

Keywords

Children, Whey, Casein, Milk minerals, Growth factors, IGF-I, Insulin

Brief summary

It is not clear which milk compounds are responsible for the growth stimulation. Through short term intervention studies in prepubertal children, we will test the effects of whey, casein, and milk minerals (especially Ca/P). Outcomes will be IGF-I, IGFBP-3, p-amino acids, oral glucose tolerance test (insulin, glucose, GLP-1 and 2, C-peptide, proinsulin) and markers for bone turn-over in blood and urine (s-osteocalcin, s-bone alkaline phosphatase, urine Dpyr, Ntx) as well as blood pressure.

Detailed description

Milk has evolved to support high growth velocity in newborns and observational and intervention studies suggest that milk has special growth stimulating properties especially regarding body size, bone mass and gut. We have previously shown that a one week high-dose intervention with milk, but not meat, increased fasting IGF-I and insulin levels in prepubertal boys. It is not clear which milk compounds are responsible for the growth stimulation. Through short term intervention studies in prepubertal children, we will test the effects of whey, casein, and milk minerals (especially Ca/P). Outcomes will be IGF-I, IGFBP-3, p-amino acids, oral glucose tolerance test (insulin, glucose, GLP-1 and 2, C-peptide, proinsulin) and markers for bone turn-over in blood and urine (s-osteocalcin, s-bone alkaline phosphatase, urine Dpyr, Ntx) as well as blood pressure. Exploring the growth stimulating effects of these milk components will improve the understanding of dietary effects on growth and bone metabolism, and will be valuable for the diary industry developing dietary products supporting growth e.g. infant formula, products for clinical nutrition and milk based products for nutritional rehabilitation of malnourished children in developing countries.

Interventions

BEHAVIORALWhey without milk minerals
BEHAVIORALWhey with milk minerals
BEHAVIORALCasein without milk minerals
BEHAVIORALCasein with milk minerals

Sponsors

ARLA Ingredients a.m.b.a.
CollaboratorUNKNOWN
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
MALE
Age
8 Years to 8 Years
Healthy volunteers
Yes

Inclusion criteria

* habital milk intake:200 - 500 mL/d

Exclusion criteria

* chronic illnesses * children who suffer from any condition likely to affect their protein metabolism or growth

Design outcomes

Primary

MeasureTime frame
IGF-I
IGFBP-3
Insulin
Glucose

Secondary

MeasureTime frame
Ghrelin
C-peptide
OGGT
Urea Nitrogen
Blood Pressure
Osteocalcin
BAP
CTX
Amino Acids
Body Composition
Adiponectin
Leptin

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026